ARYA ARYA Sciences Acquisition Corp III - Class A

ARYA Sciences Acquisition Corp III is a blank check company formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities, which it refers to as its initial business combination. It has not yet selected any business combination target. The company was founded on March 27, 2020 and is headquartered in New York, NY.

On 2/8/2021, the company announced a proposed merger with Nautilus Biotechnology, Inc. a company pioneering a single-molecule protein analysis platform for quantifying the human proteome,  

$10.04  -0.01 (-0.10%)
As of 05/10/2021 15:59:45 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Financials
Industry:  Shell Companies
Index country:  USA
Country of incorporation:  
IPO date:  12/12/2018
Outstanding shares:  15,449,000
Average volume:  89,875
Market cap:   $156,343,880
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    G3166W106
Valuation   (See tab for details)
PE ratio:   0.00
PB ratio:   38.51
PS ratio:   0.00
Return on equity:   -2.61%
Net income %:   0.00%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy